Table S1 summarizes the clinical details of 20 patients with novel CLCN5 mutations (clinical data were unavailable for three). LMWP and hypercalciuria were the most common signs at the time of their molecular diagnosis, and their clinical phenotypic variability reflected that of patients with known CLCN5 mutations [9]. Here, CLCN5 is linked to Hypercalciuria.